Leerink Partnrs Issues Optimistic Outlook for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Investment analysts at Leerink Partnrs increased their Q4 2025 earnings per share (EPS) estimates for Ardent Health Partners in a research report issued to clients and investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.68 per share for the quarter, up from their prior estimate of $0.61. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q1 2026 earnings at $0.38 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.46 EPS and Q4 2026 earnings at $0.66 EPS.

Ardent Health Partners (NYSE:ARDT) last announced its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion.

ARDT has been the subject of a number of other research reports. Royal Bank of Canada cut their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research note on Tuesday, March 4th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Stephens reaffirmed an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a research note on Tuesday. Morgan Stanley decreased their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Finally, Truist Financial lowered their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $21.18.

Ardent Health Partners Stock Down 0.0 %

NYSE:ARDT opened at $12.82 on Thursday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a fifty-two week low of $12.34 and a fifty-two week high of $20.72. The company has a fifty day moving average of $14.29 and a two-hundred day moving average of $16.10.

Institutional Investors Weigh In On Ardent Health Partners

Several hedge funds and other institutional investors have recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Ardent Health Partners in the 4th quarter valued at approximately $27,000. US Bancorp DE acquired a new position in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd acquired a new position in Ardent Health Partners in the fourth quarter valued at approximately $37,000. BNP Paribas Financial Markets purchased a new position in Ardent Health Partners in the third quarter worth approximately $42,000. Finally, New York State Common Retirement Fund acquired a new stake in Ardent Health Partners during the fourth quarter worth $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.